111 – 120 of 2289
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Future needs for continuing innovation in hemophilia : improving outcomes for individuals of all severities, including women and those in resource-constrained regions
- Contribution to journal › Scientific review
-
Mark
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
- Contribution to journal › Article
-
Mark
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
- Contribution to journal › Article
-
Mark
A deep learning approach to prediction of blood group antigens from genomic data
- Contribution to journal › Article
-
Mark
Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages : an EU COST Action cGvHD Eurograft project
- Contribution to journal › Letter
-
Mark
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
- Contribution to journal › Article
-
Mark
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
- Contribution to journal › Scientific review
-
Mark
Safe to save blood in ovarian cancer surgery : time to change transfusion habits
- Contribution to journal › Article
-
Mark
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases
- Contribution to journal › Article
-
Mark
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients
- Contribution to journal › Article
